| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 459.39 | 374.04 | 302.75 | 255.31 |
Depreciation | -75.31 | -69.77 | -68 | -31.04 |
Tax paid | -115.34 | -93.93 | -79.57 | -87.33 |
Working capital | -322.8 | 294.61 | 134.44 | 87.45 |
Other operating items | ||||
Operating | -54.05 | 504.93 | 289.61 | 224.38 |
Capital expenditure | 147 | 71.17 | 222.58 | 78.95 |
Free cash flow | 92.94 | 576.1 | 512.19 | 303.33 |
Equity raised | 2,298.51 | 1,885.68 | 1,501.9 | 1,041.1 |
Investing | 898.42 | -82.15 | 79.2 | 39.29 |
Financing | 384.14 | 0 | 0 | 0 |
Dividends paid | 115.71 | 99.11 | 98.93 | 12.27 |
Net in cash | 3,789.72 | 2,478.75 | 2,192.22 | 1,396 |
Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.
The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
